Pharma major Novartis falls 9% after three drug trial setbacks

CNBC•Tue, Sep 8, 2026, 09:23 AM•2 min read

Shares of Novartis tanked on Tuesday after results from its del-desiran drug trial disappointed investors.

Source: [CNBC](https://www.cnbc.com/2026/09/08/novartis-novn-del-desiran-drug-trial.html)

📰 Read Full Story

This is an aggregated headline summary. For the complete report, visit the original publisher.

More Headlines

FinanceSeeking Alpha• 7m ago

Developing story — details emerging. Check the source link for the latest updates.

FinanceMarketWatch• 11m ago

Earnings estimates are starting to pick up for artificial-intelligence adopters — and their stocks are due to rise as well, argues Morgan Stanley.

SportsYahoo Sports• 11m ago

Three teams are already reportedly in the mix for former New York Giants WR Darius Slayton.

FinanceInvesting.com• 12m ago

Developing story — details emerging. Check the source link for the latest updates.

FinanceSeeking Alpha• 12m ago

Developing story — details emerging. Check the source link for the latest updates.

FinanceMarketWatch• 13m ago

A spokesman for the Saudi-led coalition fighting in Yemen said 73 people were injured in attacks by the Houthi rebels.